UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001295
Receipt number R000001544
Scientific Title Phase I trial of CHP-HER2-pulsed dendritic cell vaccine for advanced breast and non-small cell lung cancer
Date of disclosure of the study information 2008/08/04
Last modified on 2009/08/07 09:35:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I trial of CHP-HER2-pulsed dendritic cell vaccine for advanced breast and non-small cell lung cancer

Acronym

CHP-HER2 dendritic cell vaccine

Scientific Title

Phase I trial of CHP-HER2-pulsed dendritic cell vaccine for advanced breast and non-small cell lung cancer

Scientific Title:Acronym

CHP-HER2 dendritic cell vaccine

Region

Japan


Condition

Condition

breast cancer, non-small cell lung cancer

Classification by specialty

Hematology and clinical oncology Surgery in general Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To assess safety of CHP-HER2-pulsed dendritic cell vaccine for advanced/metastatic breast and non-small cell lung cancer patients.

Basic objectives2

Others

Basic objectives -Others

To explore HER2-speficic immune responses and clinical anti-tumor responses.

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

adverse effect profiles, including events, frequency and grades.

Key secondary outcomes

HER2-specific immune responses
anti-tumor effects


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine Vaccine

Interventions/Control_1

subcutaneous injection of CHP-HER2-pulsed dendritic cells
each cell dose, 0.3x10E7, 1x10E7, 3x10E7
four doses every two weeks
three subjects for each cell dose, dose-escalating study

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Either of breast cancer or non-small cell lung cancer patients, who have standard-therapy-refractory disease with unrescteable stage III, IV or metastatic lesions.
Performanec status 0 to 2.
Aged 20 to 75.
Four weeks apart from the previous therapy, including surgery, chemotherapy, radiation therapy, heat therapy and other immuno-therapy.
Life expectancy of three month or longer.
preserved bone marrow, liver, kidney functions.
HER2-expression of 2+ and 3+.
Not having uncontrolled cardiac disease.
Not having interstial pneumonia.
Not having uncontrolled diabetes mellitus.
Not having auto-immune disease.
Having informed consent.

Key exclusion criteria

Pregnancy, contra-ceptive during trial entry.
Milking.
Serious bleeding tendency.
Risk of thrombosis.
Acitive infection, HIV, HCV and HBV-positives.
Serious pleural effusion, ascites and pericardial effusion.
Probable alternative drug treatment during the trial.

Target sample size

9


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takashi Nishimura, Satoshi Kondo, Masaki Mori

Organization

Hokkaido University, Institute for Genetic Medicine1), Hospital1Hokkaido University Hospital2), Kyushu University Hospital at Beppu3)

Division name

Division of Immunoregulation1), Department of Surgery2,3)

Zip code


Address

Kita-15-Jo, Nishi-7, Kita-ku, Sapporo, Hokkaido, 3-1-1, Tshurumihara, Tsurumi, Beppu, Oita, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Masaki Miyamoto1), Fumiaki Tanaka2)

Organization

Hokkaido University Hospital1), Kyushu University Beppu Medical Center2)

Division name

Department of Surgery1,2)

Zip code


Address


TEL


Homepage URL


Email

m-miyamo@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital, Kyushu University Hospital at Beppu

Institute

Department

Personal name



Funding Source

Organization

Cancer Translational Research, Ministry of Education, Culture, Sports, Science and Technology, Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 08 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2006 Year 02 Month 24 Day

Date of IRB


Anticipated trial start date

2006 Year 02 Month 01 Day

Last follow-up date

2010 Year 07 Month 01 Day

Date of closure to data entry

2010 Year 07 Month 01 Day

Date trial data considered complete

2010 Year 07 Month 01 Day

Date analysis concluded

2010 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 08 Month 04 Day

Last modified on

2009 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001544


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name